Form 8-K · Current report
Waters Corporation 8-K, filed Aug 4, 2026
- Filed
- CIK
- 0001000697
- Accession no.
- 0001193125-26-331413
Summary
Waters Corporation reported second-quarter 2026 revenue of $1.645 billion, above the high end of its guidance, with organic revenue up 9% in constant currency, and raised all components of its full-year 2026 guidance, saying the end-market recovery has broadened. GAAP diluted loss per share was $1.39 on acquisition-related purchase accounting charges, while adjusted EPS was $3.05.
Key points
- Second-quarter 2026 reported revenue was $1.645 billion, comprising $828 million of organic revenue and $817 million from the acquired Biosciences and Diagnostic Solutions businesses.
- Organic revenue grew 7% as reported and 9% in constant currency, with low-double-digit growth in the Pharma and A&G end markets.
- GAAP diluted loss per share was $1.39 versus diluted EPS of $2.47 a year earlier, reflecting amortization of acquired intangibles and inventory step-up; adjusted EPS rose 3% to $3.05.
- Full-year 2026 guidance was raised to organic constant-currency growth of 7% to 9%, acquired business reported revenue of about $3.045 billion, total revenue of $6.415 billion to $6.476 billion, and adjusted EPS of $14.45 to $14.65.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On August 4, 2026, Waters Corporation announced its results of operations for the quarter ended July 4, 2026. A copy of the related press release is furnished as Exhibit 99.1 to this Form 8-K. The information contained in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.